These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 14531815)

  • 1. End-stage renal disease in Scotland: outcomes and standards of care.
    Metcalfe W; Khan IH; Prescott GJ; Simpson K; Macleod AM;
    Kidney Int; 2003 Nov; 64(5):1808-16. PubMed ID: 14531815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can we improve early mortality in patients receiving renal replacement therapy?
    Metcalfe W; Khan IH; Prescott GJ; Simpson K; MacLeod AM
    Kidney Int; 2000 Jun; 57(6):2539-45. PubMed ID: 10844623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. UK Renal Registry 11th Annual Report (December 2008): Chapter 14 UK Renal Registry and international comparisons.
    Boddana P; Caskey F; Casula A; Ansell D
    Nephron Clin Pract; 2009; 111 Suppl 1():c269-76. PubMed ID: 19542702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. UK Renal Registry 11th Annual Report (December 2008): Chapter 6 Comorbidities and current smoking status amongst patients starting renal replacement therapy in England, Wales and Northern Ireland: national and centre-specific analyses.
    Udayaraj U; Tomson CR; Gilg J; Ansell D; Fogarty D
    Nephron Clin Pract; 2009; 111 Suppl 1():c97-111. PubMed ID: 19542707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The delivery of renal replacement therapy in Scotland--why the geographic variation?
    Boyd J; Mackinnon MW; Severn A; Traynor JP; Whitworth CE; Metcalfe W;
    QJM; 2013 Dec; 106(12):1077-85. PubMed ID: 23974056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and outcome of patients starting renal replacement therapy for end-stage renal disease due to multiple myeloma or light-chain deposit disease: an ERA-EDTA Registry study.
    Tsakiris DJ; Stel VS; Finne P; Fraser E; Heaf J; de Meester J; Schmaldienst S; Dekker F; Verrina E; Jager KJ
    Nephrol Dial Transplant; 2010 Apr; 25(4):1200-6. PubMed ID: 20037169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. UK Renal Registry 16th annual report: chapter 5 comorbidities and current smoking status amongst patients starting renal replacement therapy in England, Wales and Northern Ireland from 2011 to 2012.
    Rao A; Steenkamp R; Caskey F
    Nephron Clin Pract; 2013; 125(1-4):99-110. PubMed ID: 24662169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. UK Renal Registry 12th Annual Report (December 2009): chapter 6: comorbidities and current smoking status amongst patients starting renal replacement therapy in England, Wales and Northern Ireland from 2003 to 2008: national and centre-specific analyses.
    Caskey F; Webb L; Gilg J; Fogarty D
    Nephron Clin Pract; 2010; 115 Suppl 1():c103-16. PubMed ID: 20413944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors affecting survival in advanced chronic kidney disease patients who choose not to receive dialysis.
    Wong CF; McCarthy M; Howse ML; Williams PS
    Ren Fail; 2007; 29(6):653-9. PubMed ID: 17763158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [REIN Report 2011--summary].
    Couchoud C; Lassalle M; Jacquelinet C
    Nephrol Ther; 2013 Sep; 9 Suppl 1():S3-6. PubMed ID: 24119584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal replacement therapy for diabetic end-stage renal disease. Experience of a Tunisian hospital centre.
    Abderrahim E; Zouaghi K; Hedri H; Ben Abdallah T; Ben Hamida F; Kaaroud H; Goucha R; Ben Abdallah N; Khiari K; El Younsi F; Ben Moussa F; Kheder A; Ben Maïz H
    Diabetes Metab; 2001 Nov; 27(5 Pt 1):584-90. PubMed ID: 11694858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical practice patterns and socio-economic factors may explain geographical variation of end-stage renal disease incidence.
    Couchoud C; Guihenneuc C; Bayer F; Lemaitre V; Brunet P; Stengel B;
    Nephrol Dial Transplant; 2012 Jun; 27(6):2312-22. PubMed ID: 22121236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Predictors of early death during dialysis].
    Caravaca F; Arrobas M; Pizarro JL; Cancho B; Cubero JJ; Espárrago JF; García MC; Sánchez-Casado E
    Nefrologia; 2001; 21(3):274-82. PubMed ID: 11471308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival trends in ESRD patients compared with the general population in the United States.
    van Walraven C; Manuel DG; Knoll G
    Am J Kidney Dis; 2014 Mar; 63(3):491-9. PubMed ID: 24210591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective national study of acute renal failure treated with RRT: incidence, aetiology and outcomes.
    Prescott GJ; Metcalfe W; Baharani J; Khan IH; Simpson K; Smith WC; MacLeod AM
    Nephrol Dial Transplant; 2007 Sep; 22(9):2513-9. PubMed ID: 17517795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival of incident RRT patients in the UK (chapter 12).
    Ansell D; Roderick P; Udayaraj U; van Schalkwyk D; Tomson C
    Nephrol Dial Transplant; 2007 Aug; 22 Suppl 7():vii155-64. PubMed ID: 17724043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics and Outcomes of Granulomatosis With Polyangiitis (Wegener) and Microscopic Polyangiitis Requiring Renal Replacement Therapy: Results From the European Renal Association-European Dialysis and Transplant Association Registry.
    Hruskova Z; Stel VS; Jayne D; Aasarød K; De Meester J; Ekstrand A; Eller K; Heaf JG; Hoitsma A; Martos Jimenéz C; Ravani P; Wanner C; Tesar V; Jager KJ
    Am J Kidney Dis; 2015 Oct; 66(4):613-20. PubMed ID: 25975963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An update on renal replacement therapy in Europe: ERA-EDTA Registry data from 1997 to 2006.
    Kramer A; Stel V; Zoccali C; Heaf J; Ansell D; Grönhagen-Riska C; Leivestad T; Simpson K; Pálsson R; Postorino M; Jager K;
    Nephrol Dial Transplant; 2009 Dec; 24(12):3557-66. PubMed ID: 19820003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restricted mean survival time over 15 years for patients starting renal replacement therapy.
    Couchoud C; Dantony E; Elsensohn MH; Villar E; Vigneau C; Moranne O; Rabilloud M; Ecochard R
    Nephrol Dial Transplant; 2017 Apr; 32(suppl_2):ii60-ii67. PubMed ID: 28057870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variation in centre-specific survival in patients starting renal replacement therapy in England is explained by enhanced comorbidity information from hospitalization data.
    Fotheringham J; Jacques RM; Fogarty D; Tomson CR; El Nahas M; Campbell MJ
    Nephrol Dial Transplant; 2014 Feb; 29(2):422-30. PubMed ID: 24052459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.